This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barchiesi, F.
Right arrow Articles by Scalise, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barchiesi, F.
Right arrow Articles by Scalise, G.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2004, p. 3317-3322, Vol. 48, No. 9
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.9.3317-3322.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

In Vitro Activities of Voriconazole in Combination with Three Other Antifungal Agents against Candida glabrata

Francesco Barchiesi,1* Elisabetta Spreghini,1 Monia Maracci,1 Annette W. Fothergill,2 Isabella Baldassarri,1 Michael G. Rinaldi,2,3 and Giorgio Scalise1

Istituto di Malattie Infettive e Medicina Pubblica, Università Politecnica delle Marche, Ancona, Italy,1 Department of Pathology, The University of Texas Health Science Center at San Antonio,2 Audie Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas3

Received 2 April 2004/ Returned for modification 29 April 2004/ Accepted 14 May 2004

Candida glabrata has recently emerged as a significant pathogen involved in both superficial and deep-seated infections. In the present study, a checkerboard broth microdilution method was performed to investigate the in vitro activities of voriconazole (VOR) in combination with terbinafine (TRB), amphotericin B (AMB), and flucytosine (5FC) against 20 clinical isolates of C. glabrata. Synergy, defined as a fractional inhibitory concentration (FIC) index of ≤0.50, was observed in 75% of VOR-TRB, 10% of VOR-AMB, and 5% of VOR-5FC interactions. None of these combinations yielded antagonistic interactions (FIC index > 4). When synergy was not achieved, there was still a decrease in the MIC of one or both drugs used in the combination. In particular, the MICs were reduced to ≤1.0 µg/ml as a result of the combination for all isolates for which the AMB MIC at the baseline was ≥2.0 µg/ml. By a disk diffusion assay, the halo diameters produced by antifungal agents in combination were greater that those produced by each drug alone. Finally, killing curves showed that VOR-AMB exhibited synergistic interactions, while VOR-5FC sustained fungicidal activities against C. glabrata. These studies demonstrate that the in vitro activity of VOR against this important yeast pathogen can be enhanced upon combination with other drugs that have different modes of action or that target a different step in the ergosterol pathway. Further studies are warranted to elucidate the potential beneficial effects of such combination regimens in vivo.

* Corresponding author. Mailing address: Università Politecnica delle Marche, Azienda Ospedaliera Umberto I°, Via Conca, 60020 Torrette di Ancona, Ancona, Italy. Phone: 39.071.5963467. Fax: 39.071.5963468. E-mail: l.infettive{at}ao-umbertoprimo.marche.it.

Antimicrobial Agents and Chemotherapy, September 2004, p. 3317-3322, Vol. 48, No. 9
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.9.3317-3322.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pettit, R. K., Weber, C. A., Lawrence, S. B., Pettit, G. R., Kean, M. J., Cage, G. D. (2009). In vivo activity of anprocide alone, and in vitro activity in combination with conventional antibiotics against Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Med Microbiol 58: 1203-1206 [Abstract] [Full Text]  
  • Baltch, A. L., Bopp, L. H., Smith, R. P., Ritz, W. J., Michelsen, P. B. (2008). Anticandidal effects of voriconazole and caspofungin, singly and in combination, against Candida glabrata, extracellularly and intracellularly in granulocyte-macrophage colony stimulating factor (GM-CSF)-activated human monocytes. J Antimicrob Chemother 62: 1285-1290 [Abstract] [Full Text]  
  • Barchiesi, F., Spreghini, E., Tomassetti, S., Giannini, D., Scalise, G. (2007). Caspofungin in Combination with Amphotericin B against Candida parapsilosis. Antimicrob. Agents Chemother. 51: 941-945 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»